Octreotide Treatment for Diabetes-Related Hypoglycemia
Author Information
Author(s): Takahashi Nobuhiko, Nagamine Miho, Fukuda Mitsuko, Motomura Wataru, Abiko Atsuko, Haneda Masakazu, Fujiya Mikihiro, Ieko Masahiro, Kohgo Yutaka
Primary Institution: Health Sciences University of Hokkaido and Asahikawa Medical University
Hypothesis
Can octreotide effectively manage hypoglycemia in a patient with endogenous hyperinsulinemic hypoglycemia and protein-losing gastroenteropathy?
Conclusion
Octreotide treatment significantly reduced the frequency of hypoglycemic attacks in the patient, despite persistent hyperglycemia.
Supporting Evidence
- The patient experienced frequent hypoglycemic attacks due to endogenous hyperinsulinemia.
- Octreotide was used to manage the hypoglycemia effectively.
- Despite the reduction in hypoglycemic attacks, the patient's blood glucose levels remained high.
Takeaway
A woman with diabetes had very low blood sugar levels often, but after taking a medicine called octreotide, her low blood sugar attacks got much better.
Methodology
The patient underwent various tests including fasting tests and selective arterial calcium injection tests to diagnose the cause of hypoglycemia, and was treated with octreotide.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
52-year-old female with a history of poorly controlled diabetes and protein-losing gastroenteropathy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website